These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29016817)

  • 1. Association between socioeconomic factors and ICD implantation in a publicly financed health care system: a Danish nationwide study.
    Winther-Jensen M; Hassager C; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Christensen EF; Kragholm K; Kjaergaard J
    Europace; 2018 Jul; 20(7):1129-1137. PubMed ID: 29016817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.
    Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable Cardioverter-Defibrillators Among Older Survivors of Out-of-Hospital Cardiac Arrest.
    Marcus M; Chan PS; Chang A; Merritt RK; McNally B; Link MS; Girotra S
    J Am Heart Assoc; 2024 Oct; 13(19):e036123. PubMed ID: 39291485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable Cardioverter Defibrillator Implantation Rates After Out of Hospital Cardiac Arrest: Are the Rates Guideline-Concordant?
    Ho EC; Cheskes S; Angaran P; Morrison LJ; Aves T; Zhan C; Ko DT; Dorian P;
    Can J Cardiol; 2017 Oct; 33(10):1266-1273. PubMed ID: 28867265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of comorbidities in comatose survivors of shockable and non-shockable out-of-hospital cardiac arrest treated with target temperature management.
    Salam I; Thomsen JH; Kjaergaard J; Bro-Jeppesen J; Frydland M; Winther-Jensen M; Køber L; Wanscher M; Hassager C; Søholm H
    Scand Cardiovasc J; 2018 Jun; 52(3):133-140. PubMed ID: 29553891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.
    Elming MB; Nielsen JC; Haarbo J; Videbæk L; Korup E; Signorovitch J; Olesen LL; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Videbæk R; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Thune JJ
    Circulation; 2017 Nov; 136(19):1772-1780. PubMed ID: 28877914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study.
    Christensen AM; Bjerre J; Schou M; Jons C; Vinther M; Gislason GH; Johansen JB; Nielsen JC; Petersen HH; Riahi S; Ruwald AC
    Europace; 2019 Mar; 21(3):465-474. PubMed ID: 30535192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort.
    Ruwald MH; Ruwald AC; Johansen JB; Gislason G; Nielsen JC; Philbert B; Riahi S; Vinther M; Lindhardt TB
    Europace; 2019 Aug; 21(8):1211-1219. PubMed ID: 31329849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
    Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in patients with implantable cardioverter-defibrillators.
    Pedersen SB; Hjortshøj SP; Bøtker HE; Farkas DK; Schmidt M; Sørensen HT; Nielsen JC
    Europace; 2017 Jun; 19(6):991-1001. PubMed ID: 27256414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillator therapy in device recipients who survived a cardiac arrest associated with a reversible cause.
    Gupta A; Pasupula DK; Bhonsale A; Kancharla K; Wang NC; Adelstein E; Jain S; Saba S
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1413-1417. PubMed ID: 30015993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a risk score to predict mortality in the first year after implantable cardioverter defibrillator implantation: Data from the Israeli ICD Registry.
    Nevzorov R; Goldenberg I; Konstantino Y; Golovchiner G; Strasberg B; Souleiman M; Khalameizer V; Ben-Zvi S; Sela R; Rosenheck S; Freedberg NA; Geist M; Cohen ME; Cohen T; Shlomo N; Gabrielov-Yusim N; Geva D; Glikson M; Haim M;
    J Cardiovasc Electrophysiol; 2018 Nov; 29(11):1540-1547. PubMed ID: 30168227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation.
    Algalarrondo V; Perault R; Bories MC; Narayanan K; Garcia R; Combes N; Perier MC; Defaye P; Sadoul N; Gras D; Klug D; Bordachar P; Fauchier L; Deharo JC; Leclercq C; Boveda S; Marijon E; Babuty D;
    Arch Cardiovasc Dis; 2018 Dec; 111(12):758-765. PubMed ID: 30078651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multistate 5-Year Initiative to Improve Care for Out-of-Hospital Cardiac Arrest: Primary Results From the HeartRescue Project.
    van Diepen S; Girotra S; Abella BS; Becker LB; Bobrow BJ; Chan PS; Fahrenbruch C; Granger CB; Jollis JG; McNally B; White L; Yannopoulos D; Rea TD
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in predictors of implantable cardioverter-defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies.
    Darma A; Nedios S; Kosiuk J; Richter S; Doering M; Arya A; Rolf S; Sommer P; Hindricks G; Bollmann A
    Europace; 2016 Mar; 18(3):405-12. PubMed ID: 26056190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential cost-effectiveness of wearable cardioverter-defibrillator for patients with implantable cardioverter-defibrillator explant in a high-income city of China.
    Jiang X; Ming WK; You JHS
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2387-2396. PubMed ID: 31502350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C
    Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.